Place the Order
FAQs
We can offer a discount on bulk orders. Please contact our sales team for further inquiry.
Product Infomation
Catalog Number BIOD-007
Product Name PLGA Granule
Product overview This product is a granular copolymer of L-lactide and glycolide (PLGA), which meets the GMP standard in the pharmaceutical field and can be directly used in the production of medical devices or pharmaceutical preparations.
Morphology & Appearance White or light yellow particles
Viscosity DL-lactide and glycolide copolymer, molar ratio 65/35: 0.6 dl/g
DL-lactide and glycolide copolymer, molar ratio 80/20: 5.5 dl/g
DL-lactide and glycolide copolymer, molar ratio 82/18: 1.8 dl/g
DL-lactide and glycolide copolymer, molar ratio 85/15: 2.3 dl/g
DL-lactide and glycolide copolymer, molar ratio 85/15: 3.1 dl/g
Storage Store at 4°C.
Application Drug release: PLGA has good biocompatibility, non-toxicity, good encapsulation and film-forming properties, and is widely used in pharmaceuticals; for example, PLGA nanoparticles have high encapsulation efficiency for active drugs, which can improve their stability properties and bioavailability, commonly used in drug release systems;

Tissue engineering: PLGA microspheres or fibrous porous scaffolds have the characteristics of adjustable porosity, pore size and degradation rate, which can be used as scaffolds for cell culture and carriers of drug components, and can be implanted in vivo for blood vessels, nerves, Bone and other tissue engineering fields;

Medical devices: PLGA has good compatibility and degradability, and can be used to produce disposable infusion sets, disassembly-free surgical sutures, etc.
Online Inquiry
For Research or Industrial Raw Materials, Not For Personal Medical Use!
logo

Enter your email here to subscribe.

Copyright © MATEXCEL. All Rights Reserved.
0
Inquiry Basket